Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gene Transfer for SCID-X1 Patients
NCT01129544Phase 2Completed
- Sponsor
- David Williams
- Start
- Apr 2010
- Primary completion
- Mar 2023
- Modality
- Gene Editing, Gene Silencing, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of pSRS11.EFS.IL2RG in X-linked severe combined immunodeficiency (X-SCID), sponsored by David Williams. Started Apr 2010; status: completed.
02
Drugs
pSRS11.EFS.IL2RG
03
Conditions
X-linked severe combined immunodeficiency (X-SCID)
Beyond the preview
Go deeper on NCT01129544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01129544.